Viridian Therapeutics, Inc.
USD15.87
-1.09 (-6.43%)
CEO
Stephen F. Mahoney
IPO Date
2014-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.58
Prev. Close
$16.96
Day Low
$15.74
Day High
$16.58
52W Low
$13.18
52W High
$34.29
Market Cap
$1.43B
Volume
2.02M
| 2,031 |
| $30.19 |
| 9 Mar 2026 | Beetham Thomas W. | Chief Operating Officer | F-InKind | Disposed | 3,048 | $30.19 |
| 9 Mar 2026 | Tousignant Jennifer | Chief Legal Officer | F-InKind | Disposed | 1,675 | $30.19 |
| 9 Mar 2026 | Mahoney Stephen F. | director, officer: President and CEO | F-InKind | Disposed | 7,408 | $30.19 |
| 4 Mar 2026 | Tousignant Jennifer | Chief Legal Officer | A-Award | Acquired | 119,300 | $30.25 |
| 4 Mar 2026 | Tousignant Jennifer | Chief Legal Officer | M-Exempt | Disposed | 5,169 | $0.00 |
| 4 Mar 2026 | Tousignant Jennifer | Chief Legal Officer | A-Award | Acquired | 23,850 | $0.00 |
| 4 Mar 2026 | Tousignant Jennifer | Chief Legal Officer | M-Exempt | Acquired | 5,169 | $0.00 |
| 4 Mar 2026 | Tousignant Jennifer | Chief Legal Officer | F-InKind | Disposed | 1,724 | $29.32 |